
|Slideshows|August 28, 2017
Update on Stroke Risks
Author(s)Mark L. Fuerst
Two new studies shed light on risk factors for stroke and MI, and a third suggests neurologic use s for Zolpidem that don’t involve treating insomnia.
Advertisement
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Remyelinating Agent PIPE-307 Falls Short in Phase 2 Trial of Relapsing Multiple Sclerosis
2
Brain-Penetrant Molecule GT-02287 Demonstrates Reversal of Glucosylsphinogosine in Parkinson Disease
3
Repositioning GLP-1 Drugs for Neurologic Disease: Evidence, Advances, and Outlook
4
Understanding Multiple Sclerosis (MS) Progression: Beyond Traditional Phenotypes
5






















